Comment on "Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration"

被引：0
|
作者：
Calugaru, Dan [1 ]
Calugaru, Mihai [1 ]
机构：
[1] Univ Med, Dept Ophthalmol, Cluj Napoca 400012, Romania
来源：
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY | 2018年 / 11卷 / 11期
关键词：
POLYPOIDAL CHOROIDAL VASCULOPATHY; AFLIBERCEPT TREATMENT; CLASSIFICATION;
D O I：
10.18240/ijo.2018.11.25
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：1884 / 1885
页数：2
相关论文
共 50 条
  • [41] Long-term outcomes of intravitreal aflibercept in neovascular age-related macular degeneration with pigment epithelial detachments refractory to ranibizumab and bevacizumab
    Huo, Siya
    Chau, Felix Yan-Fay
    Lim, Jennifer I.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [42] Visual outcomes in patients with neovascular age-related macular degeneration
    Tan, Colin S.
    Ngo, Wei Kiong
    Lim, Louis W.
    ACTA OPHTHALMOLOGICA, 2018, 96 (02) : e254 - e254
  • [43] Six-year outcomes in neovascular age-related macular degeneration with ranibizumab
    Jacob, Julie
    Brie, Heidi
    Leys, Anita
    Levecq, Laurent
    Mergaerts, Filip
    Denhaerynck, Kris
    Vancayzeele, Stefaan
    Van Craeyveld, Eline
    Abraham, Ivo
    MacDonald, Karen
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2017, 10 (01) : 81 - 90
  • [44] Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema
    Fong, Angie H. C.
    Lai, Timothy Y. Y.
    CLINICAL INTERVENTIONS IN AGING, 2013, 8 : 467 - 482
  • [45] Six-year outcomes in neovascular age-related macular degeneration with ranibizumab
    Julie Jacob
    Heidi Brié
    Anita Leys
    Laurent Levecq
    Filip Mergaerts
    Kris Denhaerynck
    Stefaan Vancayzeele
    Eline Van Craeyveld
    Ivo Abraham
    Karen Mac Donald
    International Journal of Ophthalmology, 2017, 10 (01) : 81 - 90
  • [46] Long-term switching between ranibizumab and aflibercept in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
    Jae Hui Kim
    Jong Woo Kim
    Chul Gu Kim
    Dong Won Lee
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2020, 258 : 1677 - 1685
  • [47] Long-term switching between ranibizumab and aflibercept in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
    Kim, Jae Hui
    Kim, Jong Woo
    Kim, Chul Gu
    Lee, Dong Won
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2020, 258 (08) : 1677 - 1685
  • [48] Comparison of visual acuity outcomes between ranibizumab and bevacizumab treatment in neovascular age-related macular degeneration
    Feng, Xue-Feng
    Constable, Ian J.
    McAllister, Ian L.
    Isaacs, Timothy
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2011, 4 (01) : 85 - 88
  • [49] Long-Term Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration in a Clinical Setting
    Eleftheriadou, Maria
    Vazquez-Alfageme, Clara
    Citu, Cristina Maria
    Crosby-Nwaobi, Roxanne
    Sivaprasad, Sobha
    Hykin, Philip
    Hamilton, Robin D.
    Patel, Praveen J.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 174 : 160 - 168
  • [50] Long-term outcomes in eyes with early residual fluid in neovascular age-related macular degeneration
    Pedersen, Karina Else
    Wu, Anna K.
    Maatouk, Christopher
    Singh, Rishi P.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
12345